Total debt of $9.2B against equity of $5.8B yields a debt-to-equity ratio of 1.12, and while leverage has eased from 1.39 in 2024Q2, cash of $486.0M leaves a thinner liquidity cushion.
Grifols, S.A. (GRFS) balance sheet — 21-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 |
|---|
| Total Current Assets | 5.34B | 5.07B | 5.73B | 6.13B | 4.69B | 5.51B | 3.16B | 6.02B | 3.48B | 2.95B | 3.12B | 3.09B | 2.91B | 2.14B | 1.93B | 1.93B | 1.14B | 1B | 626.6M | 495.53M | 473.29M | 436.29M |
| Cash & Short-Term Investments | 486M | 824.65M | 1B | 646.04M | 580.24M | 2.69B | 590.51M | 2.76B | 1.03B | 886.52M | 895.01M | 1.14B | 1.08B | 708.78M | 473.33M | 357.49M | 252.59M | 257.59M | 13.03M | 12.77M | 33.12M | 23.52M |
| Cash Only | 486M | 824.65M | 979.78M | 529.58M | 549.21M | 655.49M | 579.65M | 832.87M | 1.03B | 886.52M | 895.01M | 1.14B | 1.08B | 708.78M | 473.33M | 340.59M | 239.65M | 249.37M | 6.37M | 5.69M | 26.88M | 22.86M |
| Short-Term Investments | 0 | 0 | 21.18M | 116.47M | 31.03M | 2.03B | 10.86M | 1.93B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.9M | 12.95M | 8.22M | 6.66M | 7.08M | 6.23M | 661K |
| Accounts Receivable | 1.08B | 844.64M | 1.08B | 692.86M | 774.2M | 434.14M | 383.23M | 528.13M | 401.57M | 385.26M | 528.52M | 477.8M | 608.33M | 462.65M | 441.79M | 528.6M | 282.99M | 252.63M | 231.81M | 200.47M | 188.87M | 158.72M |
| Days Sales Outstanding | 48.85 | 42.66 | 54.62 | 38.36 | 46.6 | 32.12 | 26.19 | 37.81 | 32.67 | 32.57 | 47.63 | 44.32 | 66.17 | 61.59 | 61.52 | 107.45 | 104.26 | 100.98 | 103.9 | 104.04 | 106.25 | 110.5 |
| Inventory | 3.47B | 3.29B | 3.56B | 3.48B | 3.24B | 2.26B | 2B | 2.63B | 1.95B | 1.63B | 1.64B | 1.43B | 1.19B | 946.91M | 998.64M | 1.03B | 527.87M | 484.46M | 373.1M | 270.66M | 235.47M | 249.54M |
| Days Inventory Outstanding | 262.33 | 258.77 | 294.13 | 309.38 | 306.77 | 277.62 | 236.91 | 348.07 | 291.94 | 274.55 | 280.54 | 260.76 | 263.16 | 261.07 | 282.27 | 805.81 | 846.54 | 1.03K | 775.16 | 550.59 | 423.03 | 591.85 |
| Other Current Assets | 311M | 100.96M | 78.58M | 1.31B | 80.88M | 131.63M | 172.88M | 78.03M | 63.1M | 33.06M | 48.32M | 31.09M | 23.67M | 232K | -192K | 1.76M | -655K | 2.95M | 5.26M | 0 | 7.71M | 4.07M |
| Total Non-Current Assets | 14.94B | 14.68B | 15.68B | 14.86B | 16.54B | 13.72B | 12.11B | 11.43B | 8.99B | 7.97B | 7.01B | 6.51B | 5.54B | 3.7B | 3.69B | 3.88B | 744.9M | 652.6M | 553.64M | 444.04M | 440.38M | 385.39M |
| Property, Plant & Equipment | 3.19B | 4.05B | 4.31B | 4.19B | 4.28B | 3.34B | 3B | 3.21B | 1.95B | 1.76B | 1.81B | 1.64B | 1.15B | 840.24M | 810.11M | 775.87M | 434.13M | 371.7M | 301.01M | 201.33M | 184.99M | 186.62M |
| Fixed Asset Turnover | 2.10x | 1.78x | 1.67x | 1.57x | 1.42x | 1.48x | 1.78x | 1.59x | 2.30x | 2.45x | 2.24x | 2.39x | 2.92x | 3.26x | 3.24x | 2.31x | 2.28x | 2.46x | 2.71x | 3.49x | 3.51x | 2.81x |
| Goodwill | 0 | 6.83B | 7.4B | 6.8B | 7.01B | 6.23B | 5.33B | 6.18B | 5.21B | 4.59B | 3.64B | 3.53B | 3.17B | 1.83B | 1.87B | 1.9B | 189.45M | 174M | 158.57M | 150.24M | 150.82M | 117.11M |
| Intangible Assets | 10.79B | 2.73B | 2.93B | 1.21B | 2.95B | 1B | 1.56B | 1.61B | 1.39B | 1.27B | 1.2B | 1.16B | 1.07B | 946.43M | 969.1M | 1.01B | 78.3M | 69.39M | 57.76M | 57.22M | 60.85M | 48.72M |
| Long-Term Investments | 1.71B | 592.75M | 528.97M | 451.9M | 1.99B | 2.27B | 2.07B | 278.35M | 228.82M | 259.06M | 232.42M | 78.08M | 58.65M | 39.13M | 5.97M | 6.76M | 8.13M | 4.11M | 2.01M | 1.13M | 2.27M | 2.41M |
| Other Non-Current Assets | 845M | 15.99M | 167.72M | 2.21B | 124.19M | 882.61M | 0 | 6.1M | 105.69M | 29.84M | 58.47M | 29.03M | 4.66M | 11.83M | 13.13M | 6.65M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 20.28B | 19.75B | 21.41B | 20.99B | 21.23B | 19.23B | 15.27B | 17.45B | 12.48B | 10.92B | 10.13B | 9.6B | 8.45B | 5.84B | 5.63B | 5.81B | 1.89B | 1.66B | 1.18B | 939.57M | 913.67M | 821.68M |
| Asset Turnover | 0.38x | 0.37x | 0.34x | 0.31x | 0.29x | 0.26x | 0.35x | 0.29x | 0.36x | 0.40x | 0.40x | 0.41x | 0.40x | 0.47x | 0.47x | 0.31x | 0.52x | 0.55x | 0.69x | 0.75x | 0.71x | 0.64x |
| Asset Growth % | -8.47% | -7.73% | 1.97% | -1.12% | 10.38% | 25.92% | -12.45% | 39.83% | 14.26% | 7.8% | 5.5% | 13.63% | 44.66% | 3.79% | -3.1% | 207.45% | 13.99% | 40.41% | 25.61% | 2.83% | 11.2% | - |
| Total Current Liabilities | 2.29B | 2.02B | 2.16B | 2.33B | 2.02B | 3.47B | 1.34B | 1.53B | 1.26B | 977.99M | 1.07B | 1.05B | 1.08B | 715.3M | 592.87M | 646.08M | 423.13M | 299.04M | 317.54M | 316.58M | 282.76M | 252.41M |
| Accounts Payable | 0 | 840.64M | 852.3M | 822.95M | 787.96M | 628.99M | 601.62M | 653.16M | 561.88M | 423.1M | 461.07M | 409.99M | 439.63M | 273.62M | 228.41M | 280.72M | 160.68M | 120.91M | 99.22M | 76.93M | 67.24M | 69.62M |
| Days Payables Outstanding | 35.22 | 66.03 | 70.42 | 73.11 | 74.7 | 77.29 | 71.18 | 86.46 | 84.15 | 71.3 | 78.73 | 74.69 | 96.89 | 75.44 | 64.56 | 219.55 | 257.68 | 256.52 | 206.13 | 156.5 | 120.79 | 165.13 |
| Short-Term Debt | 547M | 385.84M | 523.13M | 916.51M | 578.92M | 2.35B | 276.93M | 358.69M | 7.08M | 129.12M | 200.09M | 181.14M | 157.63M | 244.3M | 185M | 143.12M | 191.63M | 109.26M | 146.77M | 179.93M | 136.74M | 97M |
| Deferred Revenue (Current) | 76.97M | 76.97M | 70.86M | 0 | 37.83M | 0 | 23.98M | 24.1M | 15.53M | 14.23M | 7M | 9.19M | 20.37M | 7.46M | 166.21M | 115.57M | 52.58M | 51.91M | 36.89M | 31.95M | 45.11M | 52.02M |
| Other Current Liabilities | 1.75B | 459.8M | 81.95M | 108.6M | 381.59M | 119.44M | 264.51M | 294.78M | 507.75M | 275.65M | 115.71M | 199.19M | 147.91M | 60.9M | 61.38M | 95.62M | 50.27M | 16.93M | 33.55M | 27.66M | 54.47M | 66.18M |
| Current Ratio | 2.33x | 2.51x | 2.66x | 2.64x | 2.32x | 1.59x | 2.37x | 3.92x | 2.77x | 3.01x | 2.91x | 2.93x | 2.70x | 2.99x | 3.26x | 2.99x | 2.70x | 3.36x | 1.97x | 1.57x | 1.67x | 1.73x |
| Quick Ratio | 0.82x | 0.88x | 1.01x | 1.14x | 0.72x | 0.94x | 0.87x | 2.21x | 1.22x | 1.35x | 1.38x | 1.57x | 1.59x | 1.67x | 1.58x | 1.39x | 1.46x | 1.74x | 0.80x | 0.71x | 0.84x | 0.74x |
| Cash Conversion Cycle | 275.96 | 235.4 | 278.34 | 274.63 | 278.67 | 232.45 | 191.92 | 299.42 | 240.46 | 235.82 | 249.44 | 230.4 | 232.44 | 247.22 | 279.23 | 693.71 | 693.12 | 872.29 | 672.93 | 498.13 | 408.5 | 537.23 |
| Total Non-Current Liabilities | 9.74B | 10.12B | 10.64B | 11.15B | 11.23B | 8.44B | 7.22B | 8.22B | 6.52B | 6.31B | 5.33B | 5.25B | 4.71B | 3.02B | 3.15B | 3.5B | 758.47M | 779.61M | 381.42M | 238.83M | 262.56M | 513.33M |
| Long-Term Debt | 8.69B | 7.39B | 8.42B | 8.99B | 8.15B | 6.94B | 5.9B | 6.84B | 6.01B | 5.87B | 4.68B | 4.57B | 4.06B | 2.43B | 2.57B | 2.78B | 665.38M | 696.98M | 316.93M | 184M | 198.33M | 189.99M |
| Capital Lease Obligations | 1.9B | 968.59M | 1.02B | 1B | 914.59M | 825.16M | 690.86M | 781.58M | 9.54M | 5.42M | 6.09M | 5.85M | 9.28M | 12.1M | 17.59M | 24.62M | 4.73M | 6.2M | 7.12M | 5.49M | 0 | 0 |
| Deferred Tax Liabilities | 1.83B | 906.61M | 1.01B | 0 | 1.03B | 0 | 556.81M | 520.65M | 404.4M | 388.91M | 600.65M | 631.57M | 538.79M | 454.09M | 453.85M | 538.44M | 79.14M | 60.33M | 51.97M | 43.79M | 45.86M | 42.1M |
| Other Non-Current Liabilities | 1.05B | 854.64M | 170.46M | 1.16B | 1.12B | 675.34M | 53.93M | 77.45M | 86.37M | 29.4M | 36.09M | 30.79M | 90.01M | 119.44M | 108.18M | 137.93M | 9.21M | 14.86M | 3.04M | 999K | 18.37M | 281.23M |
| Total Liabilities | 12.04B | 12.13B | 12.8B | 13.48B | 13.25B | 11.92B | 8.55B | 9.75B | 7.78B | 7.29B | 6.4B | 6.3B | 5.79B | 3.73B | 3.75B | 4.14B | 1.18B | 1.08B | 698.96M | 555.4M | 545.32M | 765.74M |
| Total Debt | 9.24B | 8.74B | 10.09B | 11.02B | 9.75B | 10.17B | 6.91B | 7.98B | 6.03B | 6.01B | 4.89B | 4.76B | 4.24B | 2.69B | 2.78B | 2.96B | 857.02M | 817.18M | 475.76M | 373.48M | 337.21M | 293.63M |
| Net Debt | 8.75B | 7.92B | 9.11B | 10.49B | 9.2B | 9.51B | 6.33B | 7.14B | 5B | 5.12B | 3.99B | 3.62B | 3.16B | 1.98B | 2.3B | 2.62B | 617.37M | 567.8M | 469.4M | 367.79M | 310.33M | 270.77M |
| Debt / Equity | 1.12x | 1.15x | 1.17x | 1.47x | 1.22x | 1.39x | 1.03x | 1.04x | 1.28x | 1.65x | 1.31x | 1.44x | 1.59x | 1.28x | 1.48x | 1.78x | 1.21x | 1.41x | 0.99x | 0.97x | 0.92x | 5.25x |
| Debt / EBITDA | 5.32x | 5.40x | 6.19x | 8.97x | 8.17x | 10.65x | 5.25x | 5.56x | 4.93x | 4.93x | 4.28x | 4.10x | 4.05x | 3.11x | 3.52x | 8.00x | 3.35x | 3.07x | 2.01x | 2.10x | 2.60x | 2.92x |
| Net Debt / EBITDA | 5.04x | 4.89x | 5.59x | 8.53x | 7.71x | 9.96x | 4.81x | 4.98x | 4.09x | 4.20x | 3.50x | 3.12x | 3.02x | 2.29x | 2.92x | 7.08x | 2.42x | 2.13x | 1.99x | 2.07x | 2.39x | 2.69x |
| Interest Coverage | 3.64x | 1.98x | 1.35x | 1.40x | 1.76x | 2.50x | 3.87x | 3.52x | 3.65x | 3.79x | 4.12x | 4.07x | 3.78x | 3.31x | 2.28x | 1.25x | 5.63x | 17.46x | 14.60x | 13.98x | 8.86x | 5.93x |
| Total Equity | 8.24B | 7.6B | 8.61B | 7.51B | 7.98B | 7.32B | 6.72B | 7.68B | 4.7B | 3.63B | 3.73B | 3.3B | 2.66B | 2.11B | 1.88B | 1.66B | 707.39M | 578.53M | 481.28M | 384.17M | 368.35M | 55.95M |
| Equity Growth % | -3.11% | -11.7% | 14.55% | -5.8% | 9.01% | 8.88% | -12.55% | 63.62% | 29.24% | -2.52% | 12.92% | 23.98% | 26.37% | 12.04% | 12.96% | 135.37% | 22.27% | 20.21% | 25.28% | 4.29% | 558.39% | - |
| Book Value per Share | 12.11 | 11.17 | 12.66 | 11.05 | 11.73 | 10.74 | 9.80 | 11.58 | 6.86 | 5.31 | 5.45 | 4.81 | 3.89 | 3.09 | 2.74 | 2.52 | 1.60 | 1.20 | 0.99 | 0.78 | 0.86 | 0.13 |
| Total Shareholders' Equity | 5.79B | 5.27B | 5.88B | 5.37B | 5.65B | 5.52B | 5.11B | 5.41B | 4.23B | 3.63B | 3.72B | 3.3B | 2.66B | 2.1B | 1.88B | 1.66B | 693.04M | 566.37M | 480.03M | 383.19M | 367.94M | 55.83M |
| Common Stock | 120M | 119.95M | 119.6M | 119.6M | 119.6M | 119.6M | 119.6M | 134.26M | 1.03B | 1.03B | 1.03B | 1.03B | 1.03B | 1.03B | 1.01B | 117.88M | 0 | 0 | 106.53M | 106.53M | 106.53M | 70.17M |
| Retained Earnings | 390M | 0 | 156.92M | 79.36M | 0 | 248M | 618.55M | 0 | 459.89M | 539.71M | 422.55M | 412.53M | 384.31M | 276.8M | 256.69M | 50.31M | 115.51M | 147.97M | 0 | 0 | 45.39M | 25.56M |
| Treasury Stock | -129M | -130.94M | -134.45M | -152.75M | -162.22M | -164.19M | -43.73M | -55.66M | -55.44M | -62.42M | -68.71M | -58.58M | -69.25M | 0 | -3.06M | -1.93M | -1.93M | 0 | -33.09M | -28.89M | 0 | 0 |
| Accumulated OCI | 4.5B | 4.37B | 4.83B | 4.41B | 4.78B | 4.41B | 3.5B | 4.31B | 2.79B | 2.12B | 2.34B | 1.91B | 1.31B | 794.13M | 614.9M | 627.07M | 352.87M | 224.65M | 163.05M | 85.94M | 216.02M | -39.9M |
| Minority Interest | 2.46B | 2.33B | 2.72B | 2.15B | 2.33B | 1.79B | 1.61B | 2.27B | 471.05M | 4.89M | 6.5M | 5.19M | 4.76M | 5.94M | 3.97M | 2.49M | 14.35M | 12.16M | 1.25M | 981K | 408K | 121K |
Quick answers to the most common questions about buying GRFS stock.
As of 2025, Grifols, S.A. (GRFS) had total assets of $19.75B including $5.07B in current assets.
Grifols, S.A. (GRFS) carries total debt of $8.74B, offset by $824.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Grifols, S.A. (GRFS) has total shareholders' equity (book value) of $5.27B ($11.17 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Grifols, S.A. (GRFS) reported a current ratio of 2.51x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Leverage and governance overhang
Deleveraging Progress Remains Uneven
According to the reported quarterly balance sheets, Grifols' total debt fell from $11.5B in 2024Q2 to $9.2B in 2026Q3, while equity rose from $5.6B to $5.8B, suggesting the balance sheet is strengthening gradually but not decisively.
The reduction in total debt of roughly $2.3B over ten quarters indicates that management has been prioritizing repayment, yet the debt-to-equity ratio of 1.12 in 2026Q3 remains elevated relative to the earlier 1.39 peak. The improvement appears driven largely by debt paydown rather than sustained retained earnings growth, since retained earnings were near zero in several recent quarters. Investors should monitor whether further asset monetization or organic cash generation can sustain the trend without reliance on one-off transactions.
Leverage Still Dominates Capital Structure
Based on Grifols' reported figures, total liabilities of $12.0B against total assets of $20.3B in 2026Q3 imply a liabilities-to-assets ratio near 59%, with debt-to-equity at 1.12 signaling that creditors still fund more of the business than shareholders.
Leverage remains the defining feature of the balance sheet, and the 1.12 debt-to-equity ratio indicates that the capital structure is still weighted toward borrowed funds. The current ratio of 2.33 provides a comfortable short-term buffer, which suggests near-term liquidity obligations are manageable, but it does not address the long-dated refinancing exposure embedded in roughly $9.2B of debt. Cash flow durability therefore depends heavily on continued operating conversion to service this burden.
Plasma Infrastructure Anchors the Asset Base
As reported in the quarterly filings, property, plant and equipment net ranged between $3.1B and $4.3B across the period, while goodwill swung between roughly $6.8B and $11.2B, indicating an asset base dominated by intangibles and acquisition accounting.
The large goodwill component, which fluctuates materially between quarters, suggests that a meaningful share of reported asset value depends on acquisition-related valuations that may be vulnerable to impairment if plasma-derived product economics weaken. The PPE base reflects the capital intensity of collection centers and fractionation plants, consistent with a vertically integrated model. The volatility in these balance sheet lines warrants further investigation into the drivers of reclassification and consolidation adjustments.
Cash Buffer Thins Relative to Obligations
According to reported quarterly figures, cash fell from $2.1B in 2024Q2 to $486.0M in 2026Q3, meaning the liquidity cushion has narrowed considerably even as the current ratio held at 2.33.
The sharp decline in cash over the period suggests that debt reduction and acquisition-related outflows have consumed much of the liquidity built earlier, though the current ratio of 2.33 indicates working capital still covers near-term liabilities. A cash balance of roughly $486M against a $9.2B debt stack means the company relies on continued operating inflows rather than reserves to absorb shocks. This pattern appears to leave limited headroom if collection volumes or working capital reverse.
Working Capital Timing Flatters Liquidity Picture
Based on reported figures, the apparent strength in the current ratio and recent cash inflows coincides with working capital movements of $176.7M and $164.8M in 2024Q4 and 2025Q4, suggesting part of the liquidity improvement may be timing-driven.
Headline liquidity metrics may overstate the durable strength of the balance sheet because working capital inflows can reverse, and the 7-to-12-month plasma processing cycle means current inventory and receivable balances reflect collection costs from well before the reporting date. The reported debt-to-equity ratio of 1.12, which some analysts may find inconsistent with the company's historical leverage profile, further suggests that consolidation and related-party treatment could be obscuring the true obligation load. Investors should verify the consolidated debt figures before relying on the apparent improvement.